Not logged in
  Home   Markets   Shares   Funds   Portfolio   Toolbox   Charting   Alerts   Directory   
 Admin   

Wed 21 Apr 2010, 8:36 IMU - Imuniti Holdings Limited - Company Announcement
IMU
IMU                                                                             
IMU - Imuniti Holdings Limited - Company Announcement                           
Imuniti Holdings Limited                                                        
(Incorporated in the Republic of South Africa)                                  
(Registration number 2004/002282/06)                                            
(JSE Code: IMU & ISIN: ZAE000089199)                                            
("Imuniti" or "the company" or "the group")                                     
COMPANY ANNOUNCEMENT                                                            
The Board of Imuniti Holdings is pleased to announce that a five year non-      
exclusive manufacturing agreement has been entered into between Impilo          
Marketing (a subsidiary of Imuniti Holdings) and Pac-Con Pharmaceuticals in     
respect of the manufacture of the Impilo range of products and the Imuniti      
Wellness Pack.                                                                  
This agreement is effective as from 1 April 2010 and is essentially an          
extension of the previous one year agreement between the parties which has      
already brought considerable benefits to the Impilo Group.                      
Pac-Con Pharmaceuticals manufactures a wide range of personal care and other    
products for some of South Africa`s major FMCG companies and they have          
proved to be an ideal manufacturing partner for Impilo. Pac-Con is              
currently, at its own expense, undertaking a major upgrade of the Impilo        
factory which will cost in excess of R10 million and which will ensure that     
the factory is fully compliant with all the relevant MCC requirements into      
the future. Both parties are in the process of obtaining the necessary MCC      
approval for the new manufacturing arrangement. Ownership of the product        
dossiers (product formulae) remains fully the property of Impilo in terms of    
this agreement.                                                                 
A further agreement between Impilo Drugs and Pac-Con Pharmaceuticals in         
respect of the rental (with an option to purchase) of the Impilo plant and      
equipment has also been concluded.                                              
The above two agreements provide a secure platform for the supply of the        
Impilo products and the Imuniti Wellness Pack on a highly cost effective        
basis into the future.                                                          
DURBAN                                                                          
20 April 2010                                                                   
Date: 21/04/2010 08:36:02 Produced by the JSE SENS Department.                  
The SENS service is an information dissemination service administered by the    
JSE Limited (`JSE`). The JSE does not, whether expressly, tacitly or            
implicitly, represent, warrant or in any way guarantee the truth, accuracy or   
completeness of the information published on SENS. The JSE, their officers,     
employees and agents accept no liability for (or in respect of) any direct,     
indirect, incidental or consequential loss or damage of any kind or nature,     
howsoever arising, from the use of SENS or the use of, or reliance on,          
information disseminated through SENS.                                          
Profile Group (Pty) Ltd. has taken care in preparing all information on this website, but does not accept any liability for errors or out-of-date information.
Other Profile Group sites: FundsData Online (unit trust data)  |  Profile Group corporate site
Terms of Use |  Privacy Policy |  PAIA manual |  FAQs/Help |  Site Map |  © Copyright Reserved 2026  ]
  


Powered by ProfileData

Profile Mobile App Google Play Store Apple App Store


Follow us on: